@misc{indiciaecae1c3bd7f36,
  title = {Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple Sclerosis},
  author = {Afrasiabi, A. and Parnell, G. P. and Fewings, N. and Schibeci, S. D. and Basuki, M. A. and Chandramohan, R. and Brown, D. A. and Swaminathan, S. and McKay, F. C. and Stewart, G. J. and Booth, D. R.},
  year = {2018},
  doi = {10.1101/390609},
  url = {https://www.biorxiv.org/content/10.1101/390609v1},
  note = {Source identifier: 10.1101/390609}
}